The market performance of Lyra Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $6.79 on 03/27/24, while the lowest value for the same duration was $0.24 on 10/03/24.
52-week price history of LYRA Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Lyra Therapeutics Inc’s current trading price is -96.61% away from its 52-week high, while its distance from the 52-week low is -4.04%. The stock’s price range during this period has spanned from $0.24 to $6.79. In the Healthcare sector, the Lyra Therapeutics Inc’s shares surpassed a trading volume of approximately 0.78 million for the day, which was noticeably lower compared to the average daily volume of 9.0.93 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Lyra Therapeutics Inc (LYRA) has experienced a quarterly decline of -15.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 15.08M and boasts a workforce of 88 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2996, with a change in price of -0.1422. Similarly, Lyra Therapeutics Inc recorded 1,442,687 in trading volume during the last 100 days, posting a change of -38.17%.
Examining LYRA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for LYRA stands at 1.19. Similarly, the long-term debt-to-equity ratio is also 1.05.
LYRA Stock Stochastic Average
Today’s raw stochastic average for Lyra Therapeutics Inc over the last 50 days is 0.00%.This indicates a increase from the raw stochastic average of the past 20 days, which was 0.00%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 17.82% and 20.29%, respectively.
LYRA Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant loss of -95.60% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -95.64%. Over the past 30 days, the price of LYRA has leaped by -19.90%. And in the last five days, it has fallen by -4.60%.
